Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical cannabinoid enhances topical morphine antinociception.

Ozgur Yesilyurt1, Ahmet Dogrul, Husamettin Gul

  • 1Department of Pharmacology, School of Medicine, Gulhane Military Medical Academy, 06018 Etlik, Ankara, Turkey. oyesilyurt@gata.edu.tr

Pain
|September 23, 2003
PubMed
Summary

Topical cannabinoids, like WIN 55, 212-2, enhance morphine's pain-relieving effects through CB1 receptors. Combining topical cannabinoids with morphine offers a promising approach for pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

BSA-Based Nanoparticles for Dual Loading of Pazopanib and Enzalutamide: Formulation Optimization and In Vitro Evaluation in Breast Cancer Cells.

Pharmaceutics·2026
Same author

The Relationship Between Vascular Endothelial Growth Factor Expression in T Cell Subsets and Survival of Patients With Colorectal Cancer.

Cancer diagnosis & prognosis·2026
Same author

The ROI-modified mayo adhesive probability score as a predictor of postoperative fever after mini-PCNL.

World journal of urology·2026
Same author

Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.

Journal of neuro-oncology·2026
Same author

Learning curves after position switch in PCNL: prone- vs. supine-trained surgeons.

Urolithiasis·2026

Area of Science:

  • Pharmacology
  • Pain Management
  • Neuroscience

Background:

  • Opioids and cannabinoids are known analgesics with both central and peripheral actions.
  • Systemic cannabinoid administration can enhance opioid antinociception.
  • The potential for topical cannabinoid application to augment topical opioid analgesia remains largely unexplored.

Purpose of the Study:

  • To investigate if topical cannabinoids enhance the topical analgesic effects of morphine.
  • To determine the role of cannabinoid CB1 receptors in topical cannabinoid-mediated analgesia.
  • To explore the interaction between topical and spinal cannabinoids with topical morphine for pain relief.

Main Methods:

  • Mice underwent tail immersion in solutions containing WIN 55, 212-2 (cannabinoid agonist) and morphine (opioid agonist) in dimethyl sulfoxide (DMSO).

Related Experiment Videos

  • Antinociception was assessed using the radiant tail-flick test.
  • The effects of cannabinoid CB1 receptor antagonist AM 251 were evaluated on topical WIN 55, 212-2 and morphine interactions. Spinal administration of WIN 55, 212-2 was also tested.

    • Main Results:

    • Both topical morphine and WIN 55, 212-2 produced time-dependent analgesia localized to the treated tail area.
    • Topical WIN 55, 212-2 demonstrated lower potency than topical morphine but its effects were blocked by systemic CB1 antagonist AM 251.
    • Combined topical WIN 55, 212-2 and morphine produced significantly enhanced antinociception compared to morphine alone, an effect antagonized by AM 251.
    • Ineffective doses of spinally administered WIN 55, 212-2 potentiated the antinociceptive effects of topical morphine.

    Conclusions:

    • Topical cannabinoids, acting via CB1 receptors, can significantly enhance the topical analgesic efficacy of morphine.
    • Topical cannabinoid-opioid combinations represent a viable strategy for localized pain management.
    • Interactions between topical and spinal cannabinoids with topical opioids offer novel therapeutic avenues for pain control.